Biomarkers for prostate cancer and methods using the same

Details Biomarkers for prostate cancer and methods using the same Biomarkers for prostate cancer and methods using the same

G - Physics

01

N

G01N 33/574 (2006.01) A61K 38/17 (2006.01) A61P 35/00 (2006.01) C12Q 1/00 (2006.01) G01N 33/15 (2006.01) G01N 33/53 (2006.01) G01N 33/543 (2006.01)

Patent

CA 2662655

Methods for identifying and evaluating suites of biochemical and/or gene entities useful as biomarkers for early prediction of prostate cancer, disease grading, target identification/validation, and monitoring of drug efficacy are provided. Also provided are suites of small molecule entities as biomarkers for prostate cancer.

La présente invention concerne des procédés permettant d'identifier et d'évaluer des suites d'entités biochimiques et/ou génétiques servant de biomarqueurs afin d'obtenir un dépistage précoce du cancer de la prostate, déterminer la gradation de la maladie, identifier/valider la cible et surveiller l'efficacité du médicament. L'invention porte aussi sur des suites de petites entités moléculaires servant de biomarqueurs pour le cancer de la prostate.

Affiliated with

Also associated with

Rating

Biomarkers for prostate cancer and methods using the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biomarkers for prostate cancer and methods using the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers for prostate cancer and methods using the same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1496953